Positioning political buying, disclosed 2026-10-09
Options put/call open interest 0.86, read 2026-10-20
Ethical does not pass the values gate
Price23.50 USD
Fair value26.85
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-15Read Distribution22.18+6.0% to today Markdown gives way to Distribution after a 13% slide in 4 days
2026-10-11Read Markdown25.38-7.4% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-10-02Read Distribution25.38-7.4% to today ✓Markup gives way to Distribution first Distribution read since July
2026-08-23Read Markup25.15-6.6% to today Distribution gives way to Markup after an 11% rise in 7 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
AT&T holds its Distribution at $23.50. The statistical read favours the buyers, held for 3 days.
As held on the ledger · 2026-10-15
Phase
Distribution · caution
Quantitative state
The statistical read favours the buyers, held for 3 days
Price at the screen
$23.50
Valuation
7.68 trailing · 9.14 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.44
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
36.90%
Below 33%
Interest-bearing debt is 36.9% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.26%
Below 33%
Cash held in interest-bearing accounts and securities is 0.3% of assets, under the one-third limit.
Pass
Receivables
6.44%
Below 49%
Money owed to the company is 6.4% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
AT&T's business is in a permissible area, but its interest-bearing debt is about 37% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-20. It updates when the underlying figures move, and past reads are kept below.
The Conscience Overlay
Conscience flag · AFSC Investigate
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 14% discount to our $26.85 fair value, moderate competitive moat, 2.30% revenue growth.
Fair value range in USD, drawn from the 2026-10-15 screen. The gold marker is the market price at the same screen. A 14.3% margin of safety to the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +23% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Telecom Titan Buckling Under Heavy Debt
Imagine every call, every text, every byte of data that zips through the digital ether above your head - much of it is funneled through AT&T's network. It’s a company that serves as the backbone of modern communication. But here's the catch, for a company that's supposed to be as solid as a telecommunications tower, it’s staggering under a mountain of debt, which is why our ethical screen has failed it.
The numbers here are intriguing on the surface; a forward P/E of 9.8x suggests a value play, and a modest revenue growth of 2% paired with a healthy profit margin of 17% and ROE of 18% might look appealing. Yet, the moat is only moderate, and the consensus buy rating from the analysts targets a higher price. But the ethical failure, stemming from an alarming debt ratio, casts a long shadow over these financials.
Why we pass. AT&T may have been a telecommunications titan, but the risk sits heavily in its debt-laden balance sheet. The market is pricing it with a discount, yet the ethical concerns are significant. This isn’t a case of peak earnings masking a cyclical value trap; it’s a fundamental issue with financial stability that could shake investor confidence. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
T trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-21Distribution$23.50+0.0%Entry 20
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Distribution$23.50+0.0%Entry 19
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Distribution$23.50+0.0%Entry 18
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Distribution$23.50+0.0%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Distribution$23.50+0.0%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Distribution$23.50+6.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markdown$22.18-12.6%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (23 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markdown · changed$25.38+0.0%Entry 12
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (24 analysts) rates it buy, with a mean price target of $29.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (24 analysts) rates it buy, with a mean price target of $29.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
